Show simple item record

Exosome-associated AAV vector as a robust and convenient neuroscience tool

dc.contributor.authorHUDRY, E.
dc.contributor.authorMARTIN, C.
dc.contributor.authorGANDHI, S.
dc.contributor.authorGYORGY, B.
dc.contributor.authorSCHEFFER, D. I.
dc.contributor.authorMU, D.
dc.contributor.authorMERKEL, S. F.
dc.contributor.authorMINGOZZI, F.
dc.contributor.authorFITZPATRICK, Z.
dc.contributor.authorDIMANT, H.
dc.contributor.authorMASEK, M.
dc.contributor.authorRAGAN, T.
dc.contributor.authorTAN, S.
dc.contributor.authorBRISSON, Alain
dc.contributor.authorRAMIREZ, S. H.
dc.contributor.authorHYMAN, B. T.
dc.contributor.authorMAGUIRE, C. A.
dc.date.accessioned2020-09-03T07:56:16Z
dc.date.available2020-09-03T07:56:16Z
dc.date.issued2016
dc.identifier.issn0969-7128
dc.identifier.urihttps://oskar-bordeaux.fr/handle/20.500.12278/10860
dc.description.abstractEnAdeno-associated virus (AAV) vectors are showing promise in gene therapy trials and have proven to be extremely efficient biological tools in basic neuroscience research. One major limitation to their widespread use in the neuroscience laboratory is the cost, labor, skill and time-intense purification process of AAV. We have recently shown that AAV can associate with exosomes (exo-AAV) when the vector is isolated from conditioned media of producer cells, and the exo-AAV is more resistant to neutralizing anti-AAV antibodies compared with standard AAV. Here, we demonstrate that simple pelleting of exo-AAV from media via ultracentrifugation results in high-titer vector preparations capable of efficient transduction of central nervous system (CNS) cells after systemic injection in mice. We observed that exo-AAV is more efficient at gene delivery to the brain at low vector doses relative to conventional AAV, even when derived from a serotype that does not normally efficiently cross the blood-brain barrier. Similar cell types were transduced by exo-AAV and conventionally purified vector. Importantly, no cellular toxicity was noted in exo-AAV-transduced cells. We demonstrated the utility and robustness of exo-AAV-mediated gene delivery by detecting direct GFP fluorescence after systemic injection, allowing three-dimensional reconstruction of transduced Purkinje cells in the cerebellum using ex vivo serial two-photon tomography. The ease of isolation combined with the high efficiency of transgene expression in the CNS, may enable the widespread use of exo-AAV as a neuroscience research tool. Furthermore, the ability of exo-AAV to evade neutralizing antibodies while still transducing CNS after peripheral delivery is clinically relevant.
dc.language.isoen
dc.title.enExosome-associated AAV vector as a robust and convenient neuroscience tool
dc.typeArticle de revue
dc.subject.halChimie/Matériaux
bordeaux.journalGene Therapy
bordeaux.page380-392
bordeaux.volume23
bordeaux.hal.laboratoriesInstitut de Chimie & de Biologie des Membranes & des Nano-objets (CBMN) - UMR 5248*
bordeaux.hal.laboratoriesInstitut de Chimie & de Biologie des Membranes & des Nano-objets (CBMN, UMR 5248)
bordeaux.issue4
bordeaux.institutionUniversité de Bordeaux
bordeaux.institutionBordeaux INP
bordeaux.COinSctx_ver=Z39.88-2004&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.jtitle=Gene%20Therapy&rft.date=2016&rft.volume=23&rft.issue=4&rft.spage=380-392&rft.epage=380-392&rft.eissn=0969-7128&rft.issn=0969-7128&rft.au=HUDRY,%20E.&MARTIN,%20C.&GANDHI,%20S.&GYORGY,%20B.&SCHEFFER,%20D.%20I.&rft.genre=article


Files in this item

FilesSizeFormatView

There are no files associated with this item.

This item appears in the following Collection(s)

Show simple item record